Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessing Efficacy of Neoadjuvant Chemoradiotherapy as a Treatment Plan for Patients With Stage IVa Oral Cancer.

NCT03923998 is registered in ClinicalTrials.gov with Indrayani Hospital and Cancer Institute as lead sponsor.

NCT NCT03923998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03923998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessing Efficacy of Neoadjuvant Chemoradiotherapy as a Treatment Plan for Patients With Stage IVa Oral Cancer.
Lead sponsor
Indrayani Hospital and Cancer Institute
Phase
Phase 1
Overall status
Completed
Start date
March 15, 2016
Completion date
March 15, 2019
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

squamous cell carcinoma of oral cavity